Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis

Abstract

Our results, which should be confirmed in other populations, suggest that it is possible to evaluate the risk of the metabolic syndrome in a pragmatic fashion with a continuous score, obtained from principal components analysis of the basic, continuous syndrome measures.

Family physician-led, team-based, lifestyle intervention in patients with metabolic syndrome: results of a multicentre feasibility project

“…Secondary outcomes included improvement in the individual components of MetS, diet quality as determined by two 24-hour recalls 1 week apart that were used to calculate the Canadian Health Eating Index (HEI-C) 25 and Mediterranean Diet Score (MDS), 26 aerobic capacity assessed by maximal oxygen consumption (VO 2max ), 27 PROCAM score for assessing risk of myocardial infarction 11 (the PROCAM score was chosen owing to its simplicity and accuracy at predicting global risk of myocardial infarction in clinical practice and its relevance to MetS), and continuous metabolic syndrome (cMetS) score, 28 which is believed to be more sensitive than the common binary score.…”

Efficacy of a continuous metabolic syndrome score in Indian children for detecting subclinical atherosclerotic risk

“…24 Similarly, a study also claims that increasing cMetS is associated with a markedly increased age-adjusted risk of developing diabetes in adults. 25 Studies have also documented the association of BMI percentiles and physical activity with cMetS in children. 26 Thus, cMetS possibly can assess the risk of metabolic abnormalities using a more practical approach in contrast with the individual components of MS.…”

Penentuan titik potong skor sindroma metabolik remaja dan penilaian validitas diagnostik parameter antropometri: analisis Riskesdas 2013

“…Penemuan ini sejalan dengan hasil penelitian yang menggunakan data Epidemiological Study on the Insulin Resistance Syndrome (D.E.S.I.R) pada kelompok dewasa usia 30-65 tahun, bahwa laki-laki (12,4%) memiliki prevalensi lebih tinggi menderita sindroma metabolik (NCEP ATP-III) dibandingkan perempuan (7,2%) (24). Remaja Algeria dan Korea juga memiliki prevalensi sindroma metabolik (NCEP ATP-III) lebih tinggi pada remaja laki-laki (4% dan 15,4%) daripada remaja perempuan (2% dan 10%) (4,25).…”